• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Agricultural
  Analyst, 1947,72, 170-172
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 5. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl chlorides

Professional Introduction to 1-(butan-2-yl)-4-chloro-1H-pyrazole (CAS No: 1229623-54-4)

1-(butan-2-yl)-4-chloro-1H-pyrazole is a significant compound in the field of pharmaceutical chemistry, exhibiting a unique structural framework that has garnered considerable attention from researchers. This compound, identified by its CAS number 1229623-54-4, belongs to the pyrazole class of heterocyclic compounds, which are widely recognized for their diverse biological activities and potential therapeutic applications. The presence of both a butyl group and a chloro substituent in its molecular structure imparts distinct chemical properties, making it a valuable candidate for further investigation and development.

The molecular structure of 1-(butan-2-yl)-4-chloro-1H-pyrazole consists of a pyrazole ring system substituted with a butyl chain at the 1-position and a chlorine atom at the 4-position. This configuration not only influences its reactivity but also its interaction with biological targets. The butyl group enhances lipophilicity, potentially improving membrane permeability and bioavailability, while the chloro substituent can serve as a handle for further functionalization through various chemical reactions.

In recent years, there has been growing interest in exploring the pharmacological potential of pyrazole derivatives. The structural motif of 1-(butan-2-yl)-4-chloro-1H-pyrazole has been investigated for its possible role in modulating various biological pathways. For instance, studies have suggested that pyrazole derivatives can interact with enzymes and receptors involved in inflammatory responses, making them promising candidates for anti-inflammatory drugs. Additionally, the compound's ability to inhibit certain kinases has been explored, highlighting its potential in oncology research.

One of the most compelling aspects of 1-(butan-2-yl)-4-chloro-1H-pyrazole is its versatility in synthetic chemistry. The chloro group at the 4-position allows for easy introduction of other functional groups through nucleophilic substitution reactions, enabling the creation of libraries of derivatives with tailored properties. This flexibility has been exploited in high-throughput screening campaigns to identify novel bioactive molecules. Researchers have leveraged this compound as a starting point to develop inhibitors targeting specific disease-related pathways, demonstrating its importance in drug discovery efforts.

The synthesis of 1-(butan-2-yl)-4-chloro-1H-pyrazole involves multi-step organic transformations that highlight the compound's synthetic accessibility. The process typically begins with the condensation of butanone with hydrazine hydrate to form 1-butanoylhydrazine, which is then cyclized with formic acid to yield butanone hydrazide. Subsequent chlorination using reagents such as phosphorus oxychloride (POCl?) introduces the chloro substituent at the desired position on the pyrazole ring. This synthetic route underscores the compound's feasibility for large-scale production and further chemical manipulation.

Evaluation of 1-(butan-2-yl)-4-chloro-1H-pyrazole's pharmacological profile has revealed several intriguing findings. In vitro studies have demonstrated its ability to inhibit certain enzymes associated with metabolic disorders, suggesting potential applications in managing conditions such as diabetes and hyperlipidemia. Furthermore, preliminary in vivo studies indicate that this compound may exhibit neuroprotective effects, making it relevant for investigating therapies against neurodegenerative diseases like Alzheimer's and Parkinson's.

The compound's interaction with biological targets has been further elucidated through computational modeling and spectroscopic techniques. These studies have provided insights into how 1-(butan-2-yl)-4-chloro-1H-pyrazole binds to its receptors or enzymes, offering a foundation for rational drug design. By understanding these interactions at a molecular level, researchers can optimize the compound's pharmacokinetic properties and enhance its therapeutic efficacy.

The future direction of research on 1-(butan-2-yl)-4-chloro-1H-pyrazole is likely to focus on expanding its therapeutic applications and improving its safety profile. Investigating its potential as an anti-microbial agent is one area of interest, given the increasing problem of antibiotic resistance. Additionally, exploring its effects on central nervous system disorders could open new avenues for treating neurological conditions.

In conclusion, 1-(butan-2-yl)-4-chloro-1H-pyrazole (CAS No: 1229623-54-4) represents a promising compound in pharmaceutical research due to its unique structural features and diverse biological activities. Its synthesis is straightforward, allowing for easy modification and exploration of derivatives with enhanced properties. As ongoing studies continue to uncover new therapeutic potentials, this compound is poised to play a significant role in the development of next-generation pharmaceuticals.

• 1006333-97-6(3-(4-Chloro-1H-pyrazol-1-yl)butanenitrile)
• 1006320-01-9(3-(4-Chloro-1H-pyrazol-1-yl)butanethioamide)
• 1006447-90-0(3-(4-Chloro-1H-pyrazol-1-yl)propylamine)
• 63935-97-7(1H-Pyrazole, 1-(1-methylpropyl)-)
• 1006480-90-5(3-(4-Chloro-1H-pyrazol-1-yl)pentylamine)
• 1006319-94-3(3-(4-Chloro-1H-pyrazol-1-yl)propan-1-ol)
• 1001500-05-5(3-(4-Chloro-1H-pyrazol-1-yl)propanenitrile)
• 1248636-16-9(2-(4-Chloro-1H-pyrazol-1-yl)propanenitrile)
• 1006319-99-8(3-(4-Chloro-1H-pyrazol-1-yl)-2-methylpropylamine)
• 1204901-66-5(4-Chloro-1-cyclopropyl-1H-pyrazole)